Cargando…

Clinical profile and outcome of pigment-induced nephropathy

BACKGROUND: Pigment nephropathy represents one of the most severe complications of rhabdomyolysis or hemolysis. METHODS: We performed a retrospective observational study to analyze the etiology, clinical manifestation, laboratory profile and outcome in patients with biopsy-proven pigment-induced nep...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakthirajan, Ramanathan, Dhanapriya, Jeyachandran, Varghese, Arun, Saravanakumar, Karunamoorthy, Dineshkumar, Thanigachalam, Balasubramaniyan, Thopalan, Gopalakrishnan, Natarajan, Abraham Kurien, Anila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007272/
https://www.ncbi.nlm.nih.gov/pubmed/29942498
http://dx.doi.org/10.1093/ckj/sfx121
_version_ 1783333005840875520
author Sakthirajan, Ramanathan
Dhanapriya, Jeyachandran
Varghese, Arun
Saravanakumar, Karunamoorthy
Dineshkumar, Thanigachalam
Balasubramaniyan, Thopalan
Gopalakrishnan, Natarajan
Abraham Kurien, Anila
author_facet Sakthirajan, Ramanathan
Dhanapriya, Jeyachandran
Varghese, Arun
Saravanakumar, Karunamoorthy
Dineshkumar, Thanigachalam
Balasubramaniyan, Thopalan
Gopalakrishnan, Natarajan
Abraham Kurien, Anila
author_sort Sakthirajan, Ramanathan
collection PubMed
description BACKGROUND: Pigment nephropathy represents one of the most severe complications of rhabdomyolysis or hemolysis. METHODS: We performed a retrospective observational study to analyze the etiology, clinical manifestation, laboratory profile and outcome in patients with biopsy-proven pigment-induced nephropathy between January 2011 and December 2016. History, clinical examination findings, laboratory investigations and outcome were recorded. RESULTS: A total of 46 patients were included with mean follow-up of 14 ± 5.5 months. Mean age was 40.15 ± 12.3 years, 65% were males (male:female, 1.8:1) and ∼37 (80.4%) had oliguria. Mean serum creatinine at presentation and peak creatinine were 7.5 ± 2.2 and 12.1 ± 4.3 mg/dL, respectively. Evidence of rhabdomyolysis was noted in 26 patients (64%) and hemolysis in 20 patients (36%). Etiology of rhabdomyolysis include snake envenomation (10 patients), seizures (7), strenuous exercise (5), wasp sting (2) and rifampicin induced (2). The causes of hemolysis include rifampicin induced (7 patients), sepsis (5), malaria (3), mismatched blood transfusion/transfusion reaction (3) and paroxysmal nocturnal hemoglobinuria (2). On renal biopsy, two patients had acute interstitial nephritis and two had immunoglobulin A deposits in addition to pigment nephropathy. All except one (97.8%) required hemodialysis (HD) during hospital stay and mean number of HD sessions was 9 ± 2. A total of three patients with sepsis/disseminated intravascular coagulation died, all had associated hemolysis. On statistical analysis, there was no difference between AKI due to rhabdomyolysis and hemolysis except for high creatine phosphokinase in patients with rhabdomyolysis and Lactate dehydrogenase level in patients with hemolysis. At mean follow-up, five patients (12%) progressed to chronic kidney disease (CKD). CONCLUSIONS: Pigment nephropathy due to rhabdomyolysis and hemolysis is an important cause of renal failure requiring HD. The prognosis was relatively good and depends on the etiology; however, long-term studies and follow-up are needed to assess the true incidence of CKD due to pigment nephropathy.
format Online
Article
Text
id pubmed-6007272
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-60072722018-06-25 Clinical profile and outcome of pigment-induced nephropathy Sakthirajan, Ramanathan Dhanapriya, Jeyachandran Varghese, Arun Saravanakumar, Karunamoorthy Dineshkumar, Thanigachalam Balasubramaniyan, Thopalan Gopalakrishnan, Natarajan Abraham Kurien, Anila Clin Kidney J Clinical Nephrology BACKGROUND: Pigment nephropathy represents one of the most severe complications of rhabdomyolysis or hemolysis. METHODS: We performed a retrospective observational study to analyze the etiology, clinical manifestation, laboratory profile and outcome in patients with biopsy-proven pigment-induced nephropathy between January 2011 and December 2016. History, clinical examination findings, laboratory investigations and outcome were recorded. RESULTS: A total of 46 patients were included with mean follow-up of 14 ± 5.5 months. Mean age was 40.15 ± 12.3 years, 65% were males (male:female, 1.8:1) and ∼37 (80.4%) had oliguria. Mean serum creatinine at presentation and peak creatinine were 7.5 ± 2.2 and 12.1 ± 4.3 mg/dL, respectively. Evidence of rhabdomyolysis was noted in 26 patients (64%) and hemolysis in 20 patients (36%). Etiology of rhabdomyolysis include snake envenomation (10 patients), seizures (7), strenuous exercise (5), wasp sting (2) and rifampicin induced (2). The causes of hemolysis include rifampicin induced (7 patients), sepsis (5), malaria (3), mismatched blood transfusion/transfusion reaction (3) and paroxysmal nocturnal hemoglobinuria (2). On renal biopsy, two patients had acute interstitial nephritis and two had immunoglobulin A deposits in addition to pigment nephropathy. All except one (97.8%) required hemodialysis (HD) during hospital stay and mean number of HD sessions was 9 ± 2. A total of three patients with sepsis/disseminated intravascular coagulation died, all had associated hemolysis. On statistical analysis, there was no difference between AKI due to rhabdomyolysis and hemolysis except for high creatine phosphokinase in patients with rhabdomyolysis and Lactate dehydrogenase level in patients with hemolysis. At mean follow-up, five patients (12%) progressed to chronic kidney disease (CKD). CONCLUSIONS: Pigment nephropathy due to rhabdomyolysis and hemolysis is an important cause of renal failure requiring HD. The prognosis was relatively good and depends on the etiology; however, long-term studies and follow-up are needed to assess the true incidence of CKD due to pigment nephropathy. Oxford University Press 2018-06 2017-11-06 /pmc/articles/PMC6007272/ /pubmed/29942498 http://dx.doi.org/10.1093/ckj/sfx121 Text en © The Author 2017. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Clinical Nephrology
Sakthirajan, Ramanathan
Dhanapriya, Jeyachandran
Varghese, Arun
Saravanakumar, Karunamoorthy
Dineshkumar, Thanigachalam
Balasubramaniyan, Thopalan
Gopalakrishnan, Natarajan
Abraham Kurien, Anila
Clinical profile and outcome of pigment-induced nephropathy
title Clinical profile and outcome of pigment-induced nephropathy
title_full Clinical profile and outcome of pigment-induced nephropathy
title_fullStr Clinical profile and outcome of pigment-induced nephropathy
title_full_unstemmed Clinical profile and outcome of pigment-induced nephropathy
title_short Clinical profile and outcome of pigment-induced nephropathy
title_sort clinical profile and outcome of pigment-induced nephropathy
topic Clinical Nephrology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007272/
https://www.ncbi.nlm.nih.gov/pubmed/29942498
http://dx.doi.org/10.1093/ckj/sfx121
work_keys_str_mv AT sakthirajanramanathan clinicalprofileandoutcomeofpigmentinducednephropathy
AT dhanapriyajeyachandran clinicalprofileandoutcomeofpigmentinducednephropathy
AT varghesearun clinicalprofileandoutcomeofpigmentinducednephropathy
AT saravanakumarkarunamoorthy clinicalprofileandoutcomeofpigmentinducednephropathy
AT dineshkumarthanigachalam clinicalprofileandoutcomeofpigmentinducednephropathy
AT balasubramaniyanthopalan clinicalprofileandoutcomeofpigmentinducednephropathy
AT gopalakrishnannatarajan clinicalprofileandoutcomeofpigmentinducednephropathy
AT abrahamkurienanila clinicalprofileandoutcomeofpigmentinducednephropathy